Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Total Addressable Market 9
2 Report Outline 12
2.1 Report Scope 12
2.2 Report Summary 12
2.3 Research Methodology 13
2.4 Report Assumptions 14
3 Market Snapshot 15
3.1 Market Definition - Infoholic Research 15
3.2 Segmented Addressable Market (SAM) 15
3.2.1 Symptoms of Structural Heart Disease 15
3.3 Industry Trends 16
3.4 Related Markets 16
3.4.1 Cardiovascular Drugs 16
3.4.1.1 Trends of the cardiovascular drugs market 17
3.4.2 Cardiovascular Diagnostics 17
3.4.3 Prosthetic Heart Valves 18
4 Market Outlook 20
4.1 Reimbursement 20
4.2 Porter 5 (Five) Forces 23
5 Market Characteristics 25
5.1 Evolution 25
5.2 Market Segmentation 25
5.3 Market Dynamics 26
5.3.1 Drivers 26
5.3.1.1 Increase in minimally invasive surgery for structural heart diseases 26
5.3.1.2 Increasing prevalence of cardiovascular diseases 27
5.3.1.3 Increasing aging population 27
5.3.2 Restraints 28
5.3.2.1 Stringent regulatory approval process 28
5.3.2.2 Lack of skilled healthcare professionals 28
5.3.3 Opportunities 28
5.3.3.1 Increase in healthcare spending 28
5.3.3.2 Increase in the number of outpatient procedures 29
5.3.3.3 Market expansion opportunities in emerging nations 29
5.3.4 DRO - Impact Analysis 30
5.4 Key Stakeholders 31
6 Types: Market Size and Analysis 32
6.1 Overview 32
6.2 Structural Heart Repair Devices 33
6.2.1 Surgical Heart Repair Devices 35
6.2.2 Transcatheter Heart Repair Devices 35
6.3 Structural Heart Replacement Devices 37
6.3.1 Surgical Heart Replacement Devices 38
6.3.2 Transcatheter Heart Replacement Devices 40
7 End Users: Market Size and Analysis 44
7.1 Overview 44
7.2 Hospitals 44
7.3 Ambulatory Surgical Center 45
7.4 Cardiac Centers 46
8 Regions: Market Size and Analysis 47
8.1 Overview 47
8.2 North America 48
8.2.1 Overview 48
8.3 Europe 50
8.3.1 Overview 50
8.4 Asia Pacific 51
8.4.1 Overview 51
8.5 Rest of the World 53
8.5.1 Overview 53
9 Competitive Landscape 56
10 Vendors Profile 58
10.1 Abbott Laboratories 58
10.1.1 Overview 58
10.1.2 Business Units 60
10.1.3 Geographic Presence 62
10.1.4 Business Focus 62
10.1.5 SWOT Analysis 63
10.1.6 Business Strategies 63
10.2 Boston Scientific Corp. 64
10.2.1 Overview 64
10.2.2 Business Units 66
10.2.3 Geographic Presence 67
10.2.4 Business Focus 67
10.2.5 SWOT Analysis 68
10.2.6 Business Strategies 68
10.3 Medtronic plc 69
10.3.1 Overview 69
10.3.2 Business Units 78
10.3.3 Geographic Presence 79
10.3.4 Business Focus 79
10.3.5 SWOT Analysis 80
10.3.6 Business Strategies 80
10.4 Edwards Lifesciences Corp. 81
10.4.1 Overview 81
10.4.2 Business Units 83
10.4.3 Geographic Presence 84
10.4.4 Business Focus 84
10.4.5 SWOT Analysis 85
10.4.6 Business Strategies 85
10.5 LivaNova' PLC 86
10.5.1 Overview 86
10.5.2 Business Units 88
10.5.3 Geographic Presence 89
10.5.4 Business Focus 89
10.5.5 SWOT Analysis 90
10.5.6 Business Strategies 90
11 Companies to Watch for 91
11.1 Lepu Medical Technology Co.' Ltd. 91
11.1.1 Overview 91
11.1.2 Key Highlights 92
11.2 CryoLife' Inc 92
11.2.1 Overview 92
11.2.2 Key Highlights 93
11.3 JenaValve Technology GmbH 93
11.3.1 Overview 93
11.3.2 Key Highlights 94
11.4 TTK Healthcare Ltd. 94
11.4.1 Overview 94
11.4.2 Key Highlights 95
11.5 Braile Biomedica 95
11.5.1 Overview 95
Annexure 96
? Acronyms 96

?